Everything you need to know as a first-time student.
Information and support for postgraduate study.
Courses, supervisors and your life as a researcher.
Discover our campuses, courses and entry requirements.
Step-by-step application guides for our courses.
Get financial support for your studies. Find a scholarship that's right for you.
Options like part-time, external and online study can help you tailor how you learn.
Our executive education courses give you the skills you need to lead in a fast-paced world.
Boost your career or extend your skills with a short course or unit.
Our free online courses are open to everyone.
Our internationally recognised research is supported by state-of-the-art research infrastructure.
Considering research with us? Here's what to expect.
Browse our experts or find a supervisor.
PhDs, research masters and professional doctorates.
Apply for scholarships for research study, or competitive grants as a professional researcher.
Our researchers work in supportive and established networks.
We value and promote integrity and ethical responsibility in all research we conduct.
Our strengths and areas of focus in research.
A selection of world-class research from our research centres and groups.
We collaborate with industry partners to research solutions for real-world problems, and to give our students hands-on experience in the workplace.
Work with our students and graduates, sponsor scholarships, prizes or events, or become an industry partner.
We offer commercial research and consultancy services, research commercialisation, and workplace training and development.
We're working with a range of industry partners and collaborators.
Our customised executive education equips your employees with tools and inspiration to give your organisation a real edge.
We offer short courses to help you advance your career and expand your skills.
Boeing Australia have collaborated on projects with us and provided sponsorship, and their staff have taught in our avionics program.
We are a highly successful and globally positioned Australian university with an applied emphasis in courses and research.
Make a real impact by giving to QUT and supporting our students, researchers and community.
Our history, key statistics, sustainability initiatives and programs and Indigenous acknowledgement.
Meet our staff and executive team.
Our awards, accreditation details, research rankings and scholarly achievements.
Our plans for expanding our university's achievements in learning, teaching and research.
Policies, procedures and annual reports.
What's on at QUT.
Want to work with us? See available jobs.
Our campuses and facilities, including maps, research locations and public venues.
Email: email@example.com Phone: +61 7 3138 2000
Our graduates run successful businesses, conduct ground-breaking research and make significant contributions to their communities.
We celebrate our alumni with annual awards for graduates and students.
Get involved with QUT by engaging with and supporting our current students.
Once you've graduated, we encourage you to keep in touch with the QUT community and your fellow alumni.
Email: firstname.lastname@example.org Phone: +61 7 3138 4778 Mon-Fri, 8.30am-5pm
Award-winning singer-songwriter and ARIA-nominated artist Kate Miller-Heidke is the 2016 QUT Alumnus of the Year.
Step-by-step guide to applying as an international student.
We offer scholarships for international students to help with study and living costs.
You may be able to meet with a QUT staff member or official representative in your city.
Find out more about living and studying in Brisbane.
While you're studying here, you can access a range of support services to help you adjust to life in Brisbane.
Come to QUT for one or two semesters.
Freecall: 1800 181 848 (within Australia)
Phone: +61 3 9627 4853 (outside Australia)
Subscribe for email updates
A fashionable pair of earrings for women with gestational diabetes that automatically monitors and helps control blood glucose levels and a device to help brain to bladder function among geriatric patients are among the newest medical innovations being built in Brisbane.
Email: email@example.com Phone: +61 7 3138 2361
You are here:
A key physiological process holding back the successful integration of 3D printed replacement body parts for many patients has been discovered by a team of biomedical scientists.
In an article published on Nature Biomedical Engineering's website today details how the researchers of QUT's Hutmacher laboratory in collaboration with the Friedl Laboratory at MD Anderson Cancer Centre, Houston, found that an anti-osteoporotic drug and a vascular growth factor inhibitor could prevent the process that leads to implant failure. Professor Dietmar W Hutmacher, from QUT’s Australian Research Centre in Additive Biomanufacturing based in the Institute of Health and Biomedical Innovation, said medical devices and implants often failed because the patient’s body rejected them as foreign bodies. “These implants elicit a foreign body response (FBR) and cause fibrotic encapsulation or scar tissue to develop around the implant which impairs its intended function in the body,” Professor Hutmacher said. “We had to understand better the mechanisms behind the body’s response before we could find ways to change and/or guide the process so the 3D printed biodegradable scaffold can slowly dissolve away as it is replaced by new living tissue at later stages in the regeneration process. “We know that when tissue is exposed to biomaterial it triggers a step-wise process of inflammation, followed by wound healing and, if not resolved from a pro-inflammatory to a pro-reparative or regenerative mode of action, tissue fibrosis and scarring.” Professor Hutmacher said the team studied the mechanistic roles of two white blood cell types - monocyctes and macrophages – key to the body’s regeneration process. “There are two types of macrophages – M1 macrophages cause inflammation and M2 macrophages are pro-regenerative. “Both are implicated in the formation of fibrous scarring around the implant yet we did not fully understand the mechanism by which they either enhanced or counteracted the formation of fibrotic scarring in the context of a additive biomanufactured scaffold. “Our research into their role found that M1 macrophages joined and became immobilized along the scaffold surface before forming multi-nucleated giant cells which initiated a network of neovessels within the scaffold pores that acted in a way similar to the neovessels that support the growth of fibrous tissue around a tumour. “These macrophages and their giant cells produced a growth factor which led to the formation of the dense collagen capsule around the implant two to four weeks later.” Professor Hutmacher said these insights into the scaffold integration process within soft tissue suggested therapeutic intervention. “We found that administration of clodronate, an anti-osteoporosis drug, and VEGF Trap, an anti-vascular endothelial growth factor drug, significantly reduced giant-cell accumulation, and the formation of neovessels and fibrosis. “This represents a promising strategy to modulate both early inflammation and later stage tissue remodelling (weeks to month) to minimize chronic FBR and implant failure.” The research team consisted of Eleonora Dondossola, Stephanie Alexander, Stefano Filippini, and Peter Friedl from the The University of Texas MD Anderson Cancer Center, and Dietmar W. Hutmacher and Boris Holzapfel from QUT. Examination of the foreign body response to biomaterials by nonlinear intravital microscopy.
Media contact: Niki Widdowson, QUT Media, 07 3138 2999 or firstname.lastname@example.org.
After hours: Rose Trapnell, 0407 585 901 or email@example.com
Professor Dietmar W Hutmacher